The role of nicotinamide mononucleotide dependent mitochondrial reactive oxygen species generation in acute brain injury
烟酰胺单核苷酸依赖性线粒体活性氧生成在急性脑损伤中的作用
基本信息
- 批准号:9889770
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcetylationAcuteAcute Brain InjuriesAddressAffectAgeAnimal ModelAnimalsAstrocytesBioenergeticsBrainBrain InjuriesBrain regionCatabolismCause of DeathCell DeathCell SurvivalCellsChronicClinicalClinical TrialsComplexConsumptionDataDeacetylaseDeacetylationDeath RateDiseaseDoseDrug Metabolic DetoxicationEnzymesFailureFemaleFluorescenceGenerationsGlucoseGlutamate-ammonia-ligase adenylyltransferaseGoalsHealthHeart ArrestHigh PrevalenceHistologicImpairmentInjuryIschemiaIschemic Brain InjuryLeadLinkLong-Term CareMetabolicMetabolismMitochondriaMitochondrial ProteinsModelingMorphologyMyocardial InfarctionNerve DegenerationNeurodegenerative DisordersNeurologicNeurological outcomeNeuronsNicotinamide MononucleotideNicotinamide adenine dinucleotideOxygenPathologicPathway interactionsPilot ProjectsPlayPoly(ADP-ribose) PolymerasesPolymerasePopulationProcessProductionProsencephalonProtein AcetylationProteinsReactive Oxygen SpeciesRegulationResearchRespirationRespiratory physiologyRiboseRisk FactorsRoleSOD2 geneSirtuinsStrokeSuperoxidesTBI treatmentTestingTherapeuticTransgenic AnimalsTransgenic MiceTraumatic Brain InjuryVeteransWorkaging populationbrain cellcell typedeprivationdisabilityexperimental studyimprovedin vivoinsightknockout animalknockout genemalemitochondrial dysfunctionmorphometrymouse modelneuroprotectionnovelnovel therapeutic interventionnucleotide metabolismoverexpressionpre-clinical researchpreservationstroke outcomestroke riskstroke victimstherapy developmenttranslational approach
项目摘要
Impairments in mitochondrial functions have been frequently implicated in ischemic brain injury
associated with cardiac arrest or stroke. However, the extent to which mitochondrial dysfunction contributes
to neurodegeneration is unknown; and the mechanisms leading to mitochondrial failure are not well
understood. Recently, it was suggested that an imbalance in mitochondrial fission/fusion dynamics can lead
to neurodegeneration and brain damage. Furthermore, overactivation of nicotinamide adenine dinucleotide
(NAD)+ degrading poly-ADP-ribose polymerase (PARP1) causes excessive cellular and mitochondrial NAD+
depletion resulting in impaired cell survival. We hypothesize that the nicotinamide mononucleotide (NMN)
administration is inhibiting the post-ischemic neurodegeneration by (a) reversing excessive mitochondrial
fission via stimulation of mitochondrial NAD+ synthesis that (b) stimulates deacetylation of mitochondrial
proteins and leads to (c) reduction of mitochondrial superoxide production.
Our preliminary data show that treatment of animals with NAD+ precursor NMN has dramatic
neuroprotection effect, reverses the excessive mitochondrial fragmentation and increases the brain
mitochondria NAD+ levels. As a downstream result NMN is decreasing mitochondrial proteins acetylation and
inhibits mitochondrial reactive oxygen species (ROS) production. The primary goal of this study is to
determine the mechanistic link(s) between NMN induced changes in mitochondrial NAD+ metabolism, protein
acetylation, ROS generation and inhibition of fission. To address these questions, we propose to:
1. Determine the specific role of sirtuin 3 (SIRT3) in mitochondrial reactive oxygen species (ROS)
production, nucleotide metabolism, mitochondrial bioenergetic functions, and dynamics. Cells will be
prepared from our three transgenic animal models: (1) animals expressing mitochondria targeted enhanced
yellow fluorescence protein (mito-eYFP) alone, (2) animals expressing mito-eYFP and overexpressing SIRT3
(mito-eYFP-SIRT3OE), or (3) mito-eYFP expressing SIRT3 knockout animals (mito-eYFP-SIRT3KO). The
role of NMN-induced changes in mitochondrial protein acetylation on mitochondria ROS production,
mitochondrial fragmentation and cell death will be determined. Cellular NAD+ metabolism, mitochondrial
respiratory function, and mitochondrial fusion and fission will be analyzed and their role in NMN
neuroprotection and oxygen glucose deprivation induced cell death will be determined.
2. To study the specific effect of NMN treatment on post-ischemic modulation of mitochondrial
dynamics in brain, we will use our transgenic animals that will be subjected to transient forebrain ischemia
and the post-ischemic alterations in neuronal mitochondrial morphometry will be examined. In addition, NMN-
induced changes in NAD+ metabolism, mitochondrial protein acetylation and mitochondrial ROS generation
will be determined. Additionally, NMN-induced changes in NAD+ metabolism, mitochondrial protein
acetylation and mitochondrial ROS generation will be determined. Finally, we will assess the effect of NMN
treatment on post-ischemic cellular and mitochondrial NAD+ metabolism and mitochondrial respiration.
The significance of this work is that it proposes both mechanistic and translational approaches to
unravel the mechanisms of NAD+ dependent mitochondrial ROS production, impairment in mitochondrial
dynamics and determine its role in acute brain injury. Furthermore, the identification of a novel metabolic link
between NAD+ catabolism, acetylation/deacetylation of mitochondrial proteins, mitochondrial ROS generation
and inhibition of mitochondrial fission will identify new mechanisms for neuroprotection that could lead to the
use of NMN as a therapeutic compound for acute brain injury such as global ischemia, stroke and TBI or
chronic neurodegenerative disease, thus potentially have significant impact on the health of Veterans.
线粒体功能受损经常与缺血性脑损伤有关
与心脏骤停或中风有关。然而,线粒体功能障碍的程度
与神经退行性疾病的关系尚不清楚;导致线粒体衰竭的机制尚不清楚
明白了。最近,有人提出线粒体裂变/融合动力学的不平衡可能导致
神经退行性变和脑损伤。此外,烟酰胺腺嘌呤二核苷酸的过度激活
(NAD)+ 降解聚 ADP-核糖聚合酶 (PARP1) 导致细胞和线粒体 NAD+ 过多
耗竭导致细胞存活受损。我们假设烟酰胺单核苷酸(NMN)
给药通过以下方式抑制缺血后神经变性:(a) 逆转过多的线粒体
通过刺激线粒体 NAD+ 合成进行裂变,(b) 刺激线粒体脱乙酰化
蛋白质并导致 (c) 线粒体超氧化物产生减少。
我们的初步数据表明,用 NAD+ 前体 NMN 治疗动物具有显着效果。
神经保护作用,逆转线粒体过度破碎,增加大脑
线粒体 NAD+ 水平。 NMN 的下游结果是减少线粒体蛋白乙酰化,
抑制线粒体活性氧(ROS)的产生。这项研究的主要目标是
确定 NMN 诱导的线粒体 NAD+ 代谢、蛋白质变化之间的机制联系
乙酰化、ROS 产生和裂变抑制。为了解决这些问题,我们建议:
1.确定sirtuin 3(SIRT3)在线粒体活性氧(ROS)中的具体作用
生产、核苷酸代谢、线粒体生物能功能和动力学。细胞将是
从我们的三种转基因动物模型中制备:(1)表达线粒体靶向增强的动物
单独的黄色荧光蛋白 (mito-eYFP),(2) 表达 mito-eYFP 并过表达 SIRT3 的动物
(mito-eYFP-SIRT3OE),或(3)mito-eYFP表达SIRT3敲除动物(mito-eYFP-SIRT3KO)。这
NMN 诱导的线粒体蛋白乙酰化变化对线粒体 ROS 产生的作用,
将确定线粒体碎片和细胞死亡。细胞 NAD+ 代谢,线粒体
将分析呼吸功能、线粒体融合和裂变及其在 NMN 中的作用
将确定神经保护和缺氧葡萄糖剥夺诱导的细胞死亡。
2. 研究NMN治疗对线粒体缺血后调节的具体作用
在大脑动力学方面,我们将使用将遭受短暂前脑缺血的转基因动物
并将检查神经元线粒体形态测量的缺血后变化。此外,NMN-
诱导 NAD+ 代谢、线粒体蛋白乙酰化和线粒体 ROS 生成的变化
将被确定。此外,NMN 诱导 NAD+ 代谢、线粒体蛋白的变化
将确定乙酰化和线粒体 ROS 生成。最后我们来评估一下NMN的效果
对缺血后细胞和线粒体 NAD+ 代谢和线粒体呼吸的治疗。
这项工作的意义在于它提出了机械和转化方法
揭示 NAD+ 依赖的线粒体 ROS 产生、线粒体损伤的机制
动力学并确定其在急性脑损伤中的作用。此外,新的代谢联系的鉴定
NAD+ 分解代谢、线粒体蛋白乙酰化/脱乙酰化、线粒体 ROS 生成之间
线粒体裂变的抑制将确定神经保护的新机制,这可能导致
使用 NMN 作为治疗急性脑损伤(如全身缺血、中风和 TBI)的化合物,或
慢性神经退行性疾病,因此可能对退伍军人的健康产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TIBOR KRISTIAN其他文献
TIBOR KRISTIAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TIBOR KRISTIAN', 18)}}的其他基金
Using NAD+ precursor for treatment of global cerebral ischemia
利用NAD前体治疗全脑缺血
- 批准号:
10294661 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Using NAD+ precursor for treatment of global cerebral ischemia
利用NAD前体治疗全脑缺血
- 批准号:
10439887 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Using NAD+ precursor for treatment of global cerebral ischemia
利用NAD前体治疗全脑缺血
- 批准号:
10622615 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The role of nicotinamide mononucleotide dependent mitochondrial reactive oxygen species generation in acute brain injury
烟酰胺单核苷酸依赖性线粒体活性氧生成在急性脑损伤中的作用
- 批准号:
10618865 - 财政年份:2020
- 资助金额:
-- - 项目类别:
The role of nicotinamide mononucleotide dependent mitochondrial reactive oxygen species generation in acute brain injury
烟酰胺单核苷酸依赖性线粒体活性氧生成在急性脑损伤中的作用
- 批准号:
10454777 - 财政年份:2020
- 资助金额:
-- - 项目类别:
ShEEP Request for Keyence BZ-X800E All-in-One Automated Imaging System
ShEEP 请求 Keyence BZ-X800E 一体化自动化成像系统
- 批准号:
9793454 - 财政年份:2019
- 资助金额:
-- - 项目类别:
NAD catabolism and mitochondrial dysfunction in acute neurodegenerative disease
急性神经退行性疾病中 NAD 分解代谢和线粒体功能障碍
- 批准号:
8398920 - 财政年份:2011
- 资助金额:
-- - 项目类别:
NAD catabolism and mitochondrial dysfunction in acute neurodegenerative disease
急性神经退行性疾病中 NAD 分解代谢和线粒体功能障碍
- 批准号:
8696791 - 财政年份:2011
- 资助金额:
-- - 项目类别:
NAD catabolism and mitochondrial dysfunction in acute neurodegenerative disease
急性神经退行性疾病中 NAD 分解代谢和线粒体功能障碍
- 批准号:
8246297 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Nudix hydrolases and mitochondrial dynamics in acute neurodegenerative disease
急性神经退行性疾病中的 Nudix 水解酶和线粒体动力学
- 批准号:
9249385 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Standard Grant














{{item.name}}会员




